Mylan NV Ord Shs
(MYL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYL | TEVA | BBIO | RDY | SUPN |
| Company | Mylan NV Ord Shs | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 15.64 | 33.26 | 77.99 | 13.25 | 48.74 |
| High | 16.15 | 33.44 | 79.11 | 13.31 | 49.35 |
| Low | 15.34 | 32.19 | 77.21 | 13.13 | 48.09 |
| Latest | 15.86 | 33.07 | 79.10 | 13.27 | 49.06 |
| Change | +0.31 | -0.14 | +1.61 | -0.05 | +0.12 |
| % Change | +1.96% | -0.42% | +2.08% | -0.38% | +0.25% |
| Volume | 26,574,100 | 10,523,857 | 1,344,747 | 1,989,143 | 826,748 |
| 20-Day Average Volume | 8,612,350 | 10,523,752 | 2,939,227 | 1,641,407 | 658,887 |
| Previous Close | 15.55 | 33.21 | 77.49 | 13.32 | 48.94 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.15 | 32.07 | 76.96 | 13.49 | 49.98 |
| 20-Day Raw Stochastic | 86.27% | 87.69% | 78.55% | 34.07% | 26.81% |
| 20-Day Relative Strength | 55.75 | 68.82 | 59.83 | 42.59 | 48.90 |
| Weighted Alpha | -23.10 | +116.84 | +144.76 | -6.50 | +34.66 |
| Today's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Sell | 64% Buy |
| Previous Opinion | 64% Sell | 100% Buy | 100% Buy | 100% Sell | 64% Buy |
| Last Month's Opinion | 64% Sell | 100% Buy | 100% Buy | 40% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 11/09/20 | +4.45% since 01/22/26 | -1.01% since 01/22/26 | -3.21% since 01/22/26 | -0.08% since 01/22/26 |
| Low | 15.10 on 11/10/20 | 30.94 on 01/28/26 | 75.83 on 01/28/26 | 13.14 on 01/29/26 | 47.94 on 01/23/26 |
| High | 16.15 on 11/16/20 | 33.44 on 01/29/26 | 80.58 on 01/23/26 | 13.85 on 01/26/26 | 50.09 on 01/28/26 |
| 1-Month | |||||
| %Chg | +0.92% since 10/16/20 | +4.78% since 12/29/25 | +4.62% since 12/29/25 | -5.95% since 12/29/25 | -4.27% since 12/29/25 |
| Low | 14.00 on 10/29/20 | 30.47 on 01/02/26 | 70.95 on 01/12/26 | 12.81 on 01/20/26 | 47.80 on 01/06/26 |
| High | 16.15 on 11/16/20 | 33.44 on 01/29/26 | 81.32 on 01/22/26 | 14.16 on 12/31/25 | 52.50 on 01/12/26 |
| 3-Month | |||||
| %Chg | -2.07% since 08/14/20 | +63.47% since 10/29/25 | +18.73% since 10/29/25 | -1.04% since 10/29/25 | -11.89% since 10/29/25 |
| Low | 14.00 on 10/29/20 | 19.98 on 10/31/25 | 60.22 on 11/04/25 | 12.81 on 01/20/26 | 43.11 on 11/05/25 |
| High | 17.03 on 08/19/20 | 33.44 on 01/29/26 | 81.32 on 01/22/26 | 14.32 on 12/23/25 | 57.65 on 10/30/25 |
| 6-Month | |||||
| %Chg | +4.58% since 05/15/20 | +99.94% since 07/29/25 | +70.77% since 07/29/25 | -10.09% since 07/29/25 | +46.67% since 07/29/25 |
| Low | 14.00 on 10/29/20 | 14.99 on 08/01/25 | 42.09 on 08/06/25 | 12.81 on 01/20/26 | 32.83 on 07/31/25 |
| High | 19.24 on 06/08/20 | 33.44 on 01/29/26 | 81.32 on 01/22/26 | 15.06 on 09/17/25 | 57.65 on 10/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,586,212 | 38,090,540 | 14,933,019 | 11,121,374 | 2,806,171 |
| Shares Outstanding, K | 541,546 | 1,146,960 | 192,709 | 834,938 | 57,339 |
| Annual Sales | 11,500,500,000 | 16,544,000,000 | 221,900,000 | 3,811,000,000 | 661,820,000 |
| Annual Net Income | 16,800,000 | -1,639,000,000 | -535,760,000 | 663,000,000 | 73,870,000 |
| Last Quarter Sales | 2,972,100,000 | 4,480,000,000 | 120,700,000 | 977,400,000 | 192,100,000 |
| Last Quarter Net Income | 185,700,000 | 433,000,000 | -182,740,000 | 135,500,000 | -45,120,000 |
| 60-Month Beta | 1.45 | 0.66 | 1.17 | 0.37 | 0.67 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.36 on 11/06/20 | 0.96 on 01/28/26 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.01 on 11/04/25 |
| Latest Earnings Date | 02/25/21 | 01/28/26 | 02/19/26 | 05/08/26 | 02/24/26 |
| Most Recent Dividend | 0.060 on 06/27/07 | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 3.29 | 12.61 | 0.00 | 17.81 | 23.21 |